# A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer

> **NCT04394598** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 210 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** Dendrobium Huoshanense Granules
- **RADIATION:** Pelvic Radiation
- **DRUG:** Capecitabine
- **DRUG:** Irinotecan
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04394598
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04394598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04394598, "A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04394598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*